4th Quarter - Report

CAPITOL STRATEGIES GROUP, LLC for PHRMA (ON BEHALF OF WE WORK FOR HEALTH )

Period 4th Quarter 2009 Filed Jan 20, 2010 Signed by Patrick McCabe, Principle

Official filing
Firm
CAPITOL STRATEGIES GROUP, LLC
Client
PHRMA (ON BEHALF OF WE WORK FOR HEALTH )
Income
$110,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

-The impact of medical innovation on the economy -The impact of Biosimilars legislation on the pharmaceutical industry -Prevention and Wellness education programs focused on chronic disease - -H.R 1427, Promoting Innovation and Access to Life-Saving Medicine: regulatory approval for follow-on biologics,including provisions on data exclusivity and patient procedures for biologics -H.R, 1548, Pathway for Biosimiloars Act: regulatory approval for follow-on biologics,including provisions on data exclusivity and patient procedures for biologics -S.726, Promoting Innovation and Access to Life-Saving Medicine: regulatory approval for follow-on biologics,including provisions on data exclusivity and patient procedures for biologics

LobbyistCovered position, as disclosed
P.J. CIMINI —
PATRICK E MCCABE New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 726 (111th), H.R. 1427 (111th)

Pharmacy PHA

-The impact of medical innovation on the economy -The impact of Biosimilars legislation on the pharmaceutical industry -Prevention and Wellness education programs focused on chronic disease - -H.R 1427, Promoting Innovation and Access to Life-Saving Medicine: regulatory approval for follow-on biologics,including provisions on data exclusivity and patient procedures for biologics -H.R, 1548, Pathway for Biosimiloars Act: regulatory approval for follow-on biologics,including provisions on data exclusivity and patient procedures for biologics -S.726, Promoting Innovation and Access to Life-Saving Medicine: regulatory approval for follow-on biologics,including provisions on data exclusivity and patient procedures for biologics

LobbyistCovered position, as disclosed
P.J. CIMINI —
PATRICK E MCCABE New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1427 (111th), S. 726 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.